The University of Chicago Header Logo

Connection

Suzanne Conzen to Receptors, Estrogen

This is a "connection" page, showing publications Suzanne Conzen has written about Receptors, Estrogen.
Connection Strength

1.817
  1. Glucocorticoid receptor modulation decreases ER-positive breast cancer cell proliferation and suppresses wild-type and mutant ER chromatin association. Breast Cancer Res. 2019 07 24; 21(1):82.
    View in: PubMed
    Score: 0.531
  2. GR and ER Coactivation Alters the Expression of Differentiation Genes and Associates with Improved ER+ Breast Cancer Outcome. Mol Cancer Res. 2016 08; 14(8):707-19.
    View in: PubMed
    Score: 0.425
  3. Activation of the glucocorticoid receptor is associated with poor prognosis in estrogen receptor-negative breast cancer. Cancer Res. 2011 Oct 15; 71(20):6360-70.
    View in: PubMed
    Score: 0.307
  4. Glucocorticoid receptor-mediated oncogenic activity is dependent on breast cancer subtype. J Steroid Biochem Mol Biol. 2024 10; 243:106518.
    View in: PubMed
    Score: 0.185
  5. Mammary Adipose Tissue-Derived Lysophospholipids Promote Estrogen Receptor-Negative Mammary Epithelial Cell Proliferation. Cancer Prev Res (Phila). 2016 05; 9(5):367-78.
    View in: PubMed
    Score: 0.105
  6. Glucocorticoid receptor antagonism as a novel therapy for triple-negative breast cancer. Clin Cancer Res. 2013 Nov 15; 19(22):6163-72.
    View in: PubMed
    Score: 0.088
  7. Minireview: nuclear receptors and breast cancer. Mol Endocrinol. 2008 Oct; 22(10):2215-28.
    View in: PubMed
    Score: 0.061
  8. Overcoming oncogene addiction in breast and prostate cancers: a comparative mechanistic overview. Endocr Relat Cancer. 2021 02; 28(2):R31-R46.
    View in: PubMed
    Score: 0.037
  9. Discovery of a Glucocorticoid Receptor (GR) Activity Signature Using Selective GR Antagonism in ER-Negative Breast Cancer. Clin Cancer Res. 2018 07 15; 24(14):3433-3446.
    View in: PubMed
    Score: 0.030
  10. Racial disparities in omission of oncotype DX but no racial disparities in chemotherapy receipt following completed oncotype DX test results. Breast Cancer Res Treat. 2018 Feb; 168(1):207-220.
    View in: PubMed
    Score: 0.030
  11. Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer. J Clin Oncol. 2011 Jul 01; 29(19):2645-52.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.